Dispositional mindfulness, anticipation and abstinence symptoms related to hypnotic dependence among insomniac women who seek treatment: A cross-sectional study
- PMID: 29547622
- PMCID: PMC5856331
- DOI: 10.1371/journal.pone.0194035
Dispositional mindfulness, anticipation and abstinence symptoms related to hypnotic dependence among insomniac women who seek treatment: A cross-sectional study
Abstract
Introduction: Dispositional mindfulness can be described as the mental ability to pay attention to the present moment, non-judgmentally. There is evidence of inverse relation between dispositional mindfulness and insomnia and substance use, but as of yet, no studies evaluating the specific association between dispositional mindfulness and the components of hypnotic use disorder.
Objective: To evaluate the association between dispositional mindfulness and the components of dependence among female chronic hypnotic users.
Design and method: Seventy-six women, chronic users of hypnotics, who resorted to Mindfulness-Based Relapse Prevention for the cessation of hypnotic use were included in the study. The Five Facet Mindfulness Questionnaire (FFMQ) evaluated the levels and facets of mindfulness, and the subscales of the Benzodiazepine Dependence Questionnaire (BENDEP) assessed dependence on hypnotics. We also evaluated sociodemographic variables and symptoms of insomnia and anxiety. The associations between the FFMQ facets and the BENDEP subscales were evaluated with binomial logistic regression, adjusted for income, schooling, anxiety, and insomnia.
Results: We observed associations between facets of the FFMQ and specific aspects of hypnotic dependence. The facet "observing" was inversely associated with the "concern about lack of availability of the hypnotic" [aOR = 0.87 95% CI (0.79-0.97)], and the facet "non-reacting to inner experience" with "noncompliance with the prescription recommendations" [aOR = 0.86 95% CI (0.75-0.99)]. The total score of the FFMQ was inversely associated to those two dependence subscales [aOR = 0.94 95% CI (0.89-0.99)]. "Observing" and "non-reactivity to inner experience" were also inversely associated with the "impairments related to the withdrawal symptoms" [aOR = 0.84 95% CI (0.73-0.97)] and [aOR = 0.78 95% CI (0.63-0.96)], respectively. The FFMQ was not associated with "awareness of problematic hypnotic use".
Conclusion: Dispositional mindfulness, specifically the facets "observing" and "non-reactivity to inner experience, were inversely associated with the components of hypnotic dependence related to the anticipation of having the substance, its expected effect, and the impairments caused by the abstinence. We discuss the implications of those results for the clinical practice and future investigations.
Conflict of interest statement
Similar articles
-
The Role of Mindfulness in the Insomnia Severity of Female Chronic Hypnotic Users.Int J Behav Med. 2018 Oct;25(5):526-531. doi: 10.1007/s12529-018-9724-1. Int J Behav Med. 2018. PMID: 29728990
-
The "what" and the "how" of dispositional mindfulness: using interactions among subscales of the five-facet mindfulness questionnaire to understand its relation to substance use.Assessment. 2012 Sep;19(3):276-86. doi: 10.1177/1073191112446658. Epub 2012 May 14. Assessment. 2012. PMID: 22589412 Free PMC article.
-
What is the mindful personality? Implications for physical and psychological health.Acta Psychol (Amst). 2022 Apr;224:103514. doi: 10.1016/j.actpsy.2022.103514. Epub 2022 Feb 1. Acta Psychol (Amst). 2022. PMID: 35121346
-
[Insomnia due to hypnotic abuse].Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(11. Vyp. 2):24-29. doi: 10.17116/jnevro201611611224-29. Zh Nevrol Psikhiatr Im S S Korsakova. 2016. PMID: 28300810 Review. Russian.
-
Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.Health Technol Assess. 2004 Feb;8(8):iii-iv, 1-68. doi: 10.3310/hta8080. Health Technol Assess. 2004. PMID: 14960254 Review.
Cited by
-
The Role of Mindfulness in the Insomnia Severity of Female Chronic Hypnotic Users.Int J Behav Med. 2018 Oct;25(5):526-531. doi: 10.1007/s12529-018-9724-1. Int J Behav Med. 2018. PMID: 29728990
References
-
- Donoghue J, Lader M. Usage of benzodiazepines: A review. International journal of psychiatry in clinical practice. 2010;14(2):78–87. Epub 2010/06/01. doi: 10.3109/13651500903447810 . - DOI - PubMed
-
- Nappo SA, Carlini EA, Araújo MD, Moreira LFS. Prescription of anorectic and benzodiazepine drugs through notification B prescriptions in Natal, Rio Grande do Norte, Brazil. Braz J Pharm Sci. 2010;46(2):297–303.
-
- Dell'osso B, Lader M. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. European Psychiatry. 2013;28(1):7–20. doi: 10.1016/j.eurpsy.2011.11.003 - DOI - PubMed
-
- Bertisch SM, Herzig SJ, Winkelman JW, Buettner C. National use of prescription medications for insomnia: NHANES 1999–2010. Sleep. 2014;37(2):343–9. Epub 2014/02/06. doi: 10.5665/sleep.3410 . - DOI - PMC - PubMed
-
- Stranks EK, Crowe SF. The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis. Journal of clinical and experimental neuropsychology. 2014;36(7):691–700. Epub 2014/06/17. doi: 10.1080/13803395.2014.928268 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical